Table 3.
Patient Demographics, n = 55
| Age (mean) years (SD), range | 72.0 (16.7), 26–98 |
| Sex, male, n (%) | 30 (55) |
| Race, n (%) | |
| White | 25 (45) |
| Black or African American | 12 (22) |
| Asian | 6 (11) |
| Hispanic or Latino | 12 (22) |
| CKD stage, n (%) | |
| Stage II or III | 3 (5) |
| Stage IV | 6 (11) |
| Stage V | 46 (84) |
| Therapy choice, n (%) | |
| Renal replacement therapy | 23 (42) |
| Conservative management | 14 (25) |
| Deciding | 11 (20) |
| Plan for renal replacement therapy | 4 (7) |
| Neither | 3 (5) |
| CCI score, n (%) | |
| x ≤ 5 | 14 (25) |
| 5 < x ≤ 8 | 16 (29) |
| 8 < x ≤ 17 | 25 (46) |
| Karnofsky Performance Score, mean (SD), range | 57.7 (20.2), 20–100 |
| Number of symptoms, mean (SD) | 7.5 (3.7) |
| Symptom burden, mean (SD) | 16.1 (9.1) |
| Number of follow-up visits, n (%) | |
| 1 | 29 (53) |
| 2 | 26 (25) |
| 3–4 | 7 (13) |
| 5+ | 5 (9) |
CCI, Charlson Comorbidity Index; SD, standard deviation.